Literature DB >> 19801547

Calnexin improves the folding efficiency of mutant rhodopsin in the presence of pharmacological chaperone 11-cis-retinal.

Syed M Noorwez1, Reddy Ranjith K Sama, Shalesh Kaushal.   

Abstract

The lectin chaperone calnexin (Cnx) is important for quality control of glycoproteins, and the chances of correct folding of a protein increase the longer the protein interacts with Cnx. Mutations in glycoproteins increase their association with Cnx, and these mutant proteins are retained in the endoplasmic reticulum. However, until now, the increased interaction with Cnx was not known to increase the folding of mutant glycoproteins. Because many human diseases result from glycoprotein misfolding, a Cnx-assisted folding of mutant glycoproteins could be beneficial. Mutations of rhodopsin, the glycoprotein pigment of rod photoreceptors, cause misfolding resulting in retinitis pigmentosa. Despite the critical role of Cnx in glycoprotein folding, surprisingly little is known about its interaction with rhodopsin or whether this interaction could be modulated to increase the folding of mutant rhodopsin. Here, we demonstrate that Cnx preferentially associates with misfolded mutant opsins associated with retinitis pigmentosa. Furthermore, the overexpression of Cnx leads to an increased accumulation of misfolded P23H opsin but not the correctly folded protein. Finally, we demonstrate that increased levels of Cnx in the presence of the pharmacological chaperone 11-cis-retinal increase the folding efficiency and result in an increase in correct folding of mutant rhodopsin. These results demonstrate that misfolded rather than correctly folded rhodopsin is a substrate for Cnx and that the interaction between Cnx and mutant, misfolded rhodopsin, can be targeted to increase the yield of folded mutant protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801547      PMCID: PMC2785176          DOI: 10.1074/jbc.M109.043364

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa.

Authors:  C H Sung; B G Schneider; N Agarwal; D S Papermaster; J Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

2.  N-linked glycosylation of Drosophila rhodopsin occurs exclusively in the amino-terminal domain and functions in rhodopsin maturation.

Authors:  K Katanosaka; F Tokunaga; S Kawamura; K Ozaki
Journal:  FEBS Lett       Date:  1998-03-13       Impact factor: 4.124

3.  Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin.

Authors:  Carlos M Farinha; Margarida D Amaral
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  Association between calnexin and a secretion-incompetent variant of human alpha 1-antitrypsin.

Authors:  A Le; J L Steiner; G A Ferrell; J C Shaker; R N Sifers
Journal:  J Biol Chem       Date:  1994-03-11       Impact factor: 5.157

5.  Calnexin expression does not enhance the generation of MHC class I-peptide complexes.

Authors:  S A Prasad; J W Yewdell; A Porgador; B Sadasivan; P Cresswell; J R Bennink
Journal:  Eur J Immunol       Date:  1998-03       Impact factor: 5.532

6.  Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells.

Authors:  Christopher T Esapa; R A Jeffrey McIlhinney; Derek J Blake
Journal:  Hum Mol Genet       Date:  2004-12-01       Impact factor: 6.150

7.  Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa.

Authors:  S Kaushal; H G Khorana
Journal:  Biochemistry       Date:  1994-05-24       Impact factor: 3.162

8.  Retinoids assist the cellular folding of the autosomal dominant retinitis pigmentosa opsin mutant P23H.

Authors:  Syed M Noorwez; Ritu Malhotra; J Hugh McDowell; Karen A Smith; Mark P Krebs; Shalesh Kaushal
Journal:  J Biol Chem       Date:  2004-02-09       Impact factor: 5.157

9.  Biphasic photoreceptor degeneration induced by light in a T17M rhodopsin mouse model of cone bystander damage.

Authors:  Mark P Krebs; D Alan White; Shalesh Kaushal
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-10       Impact factor: 4.799

Review 10.  Calnexin, calreticulin, and ERp57: teammates in glycoprotein folding.

Authors:  Lars Ellgaard; Eva-Maria Frickel
Journal:  Cell Biochem Biophys       Date:  2003       Impact factor: 2.194

View more
  26 in total

Review 1.  Protein misfolding and retinal degeneration.

Authors:  Radouil Tzekov; Linda Stein; Shalesh Kaushal
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-11-01       Impact factor: 10.005

Review 2.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

Review 3.  Endoplasmic reticulum stress and the unfolded protein responses in retinal degeneration.

Authors:  Sarah X Zhang; Emily Sanders; Steven J Fliesler; Joshua J Wang
Journal:  Exp Eye Res       Date:  2014-05-02       Impact factor: 3.467

4.  AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.

Authors:  Haoyu Mao; Thomas James; Alison Schwein; Arseniy E Shabashvili; William W Hauswirth; Marina S Gorbatyuk; Alfred S Lewin
Journal:  Hum Gene Ther       Date:  2011-03-07       Impact factor: 5.695

Review 5.  Endoplasmic reticulum-associated degradation (ERAD) of misfolded glycoproteins and mutant P23H rhodopsin in photoreceptor cells.

Authors:  Heike Kroeger; Wei-Chieh Chiang; Jonathan H Lin
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

6.  Accumulation of the Raf-1 kinase inhibitory protein (Rkip) is associated with Cep290-mediated photoreceptor degeneration in ciliopathies.

Authors:  Carlos A Murga-Zamalloa; Amiya K Ghosh; Suresh B Patil; Nathan A Reed; Lan Sze Chan; Supriya Davuluri; Johan Peränen; Toby W Hurd; Rivka A Rachel; Hemant Khanna
Journal:  J Biol Chem       Date:  2011-06-17       Impact factor: 5.157

Review 7.  The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy.

Authors:  Dimitra Athanasiou; Monica Aguila; James Bellingham; Wenwen Li; Caroline McCulley; Philip J Reeves; Michael E Cheetham
Journal:  Prog Retin Eye Res       Date:  2017-10-16       Impact factor: 21.198

8.  Transcriptome profiling of NIH3T3 cell lines expressing opsin and the P23H opsin mutant identifies candidate drugs for the treatment of retinitis pigmentosa.

Authors:  Yuanyuan Chen; Matthew J Brooks; Linn Gieser; Anand Swaroop; Krzysztof Palczewski
Journal:  Pharmacol Res       Date:  2016-11-09       Impact factor: 7.658

Review 9.  Gene augmentation for adRP mutations in RHO.

Authors:  Alfred S Lewin; Brian Rossmiller; Haoyu Mao
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-18       Impact factor: 6.915

Review 10.  Pharmacological chaperoning: a primer on mechanism and pharmacology.

Authors:  Nancy J Leidenheimer; Katelyn G Ryder
Journal:  Pharmacol Res       Date:  2014-02-14       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.